Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Journal of Cardiovascular Translational Research, 2022
Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome

Christersson C., Baron T., Flachskampf F. et al.

Olink Target 96CVDPathophysiologyPlasma

iScience, 2022
Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

Buyukozkan M., Alvarez-Mulett S., Racanelli A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationSerum

International Journal of Cardiology, 2022
Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)

de Lange I., Petersen T., de Bakker M. et al.

Olink Target 96CVDPatient StratificationPlasma

Brain Communications, 2022
Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment

Kivisäkk P., Magdamo C., Trombetta B. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Molecular Psychiatry, 2022
Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study

Sandberg J., Hansson C., Göteson A. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Nature Communications, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

Damsky W., Wang A., Kim D. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Communications Biology, 2022
Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort

Yang J., Jia Z., Song X. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma

BMC Women's Health, 2022
Applicability of polygenic risk scores in endometriosis clinical presentation

Svensson A., Garcia-Etxebarria K., Åkesson A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum

Kidney Medicine, 2022
Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Schmidt I., Colona M., Srivastava A. et al.

Olink Target 96Immunological & Inflammatory DiseasesTechnical EvaluationPlasma

Journal of the American College of Cardiology, 2022
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data

Tayal U., Verdonschot J., Hazebroek M. et al.

Olink Target 96CVDPatient StratificationSerum

Annals of Oncology, 2022
Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

Bessede A., Marabelle A., Guégan J. et al.

OncologyImmunotherapyPatient Stratification

Multiple Sclerosis and Related Disorders, 2022
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL

Gawde S., Agasing A., Bhatt N. et al.

Olink Target 96NeurologyPatient StratificationSerum

Atherosclerosis, 2022
Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach

Shafi B., Bøttcher M., Ejupi A. et al.

Olink Target 96CVDPathophysiology

Osteoporosis International, 2022
Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial

Sköld C., Kultima K., Freyhult E. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologySerum

eBioMedicine, 2022
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

Jones D., Wetten A., Barron-Millar B. et al.

Olink Target 96HepatologyPatient StratificationSerum

European Journal of Heart Failure, 2022
Distinct pathophysiological pathways in women and men with heart failure

Ravera A., Santema B., de Boer R. et al.

Olink Target 96CVDPathophysiologyPlasma

Clinical Kidney Journal, 2022
Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes

Laursen J., Søndergaard-Heinrich N., Haddock B. et al.

Olink Target 96Metabolic DiseasesNephrologyPathophysiologyPlasma

Scientific Reports, 2022
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction

Girerd N., Cleland J., Anker S. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Scientific Reports, 2022
Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome

Niroomand A., Ghaidan H., Hallgren O. et al.

Olink Target 96Respiratory DiseasesPatient StratificationPlasma

Journal of Nephrology, 2022
Assay-related differences in SuPAR levels: implications for measurement and data interpretation

Vasbinder A., Raffield L., Gao Y. et al.

Olink Target 96NephrologyTechnical EvaluationPlasma

2846 publications